AwardedSpainGoodsFramework agreement€2,801,610
Contratos basados en el Acuerdo Marco 202507ACM001, para la selección de suministradores de vacunas de calendario y otras y otros productos inmunizantes para determinados órganos de contratación de la AGE y las ciudades de Ceuta y Melilla y varias CCAA, lotes 6 y 13 para la anualidad de 2026 en la Comunidad de Madrid.
- Published
- Published 19 June 2026
Overview
The Madrid Regional Health Authority has awarded contracts for the supply of vaccines under a framework agreement: lot 6 for hepatitis B vaccine for pediatric patients and lot 13 for measles, rubella, mumps, and varicella vaccine for 2026. The award was made on 4 June 2026 to GlaxoSmithKline, S.A. and Merck Sharp & Dohme de España, S.A. for a total value of €2,622,474.40, in accordance with recommendations approved by the National Health System Interterritorial Council in January 2024.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,801,610
- Procedure
- Direct
- Contract type
- Framework agreement
- Published
- 19 June 2026
Vaccines
Award outcome
- Awarded value
- €2,622,474
- Award date
- 4 June 2026
- Contract period
- 21 May 2026 → 30 November 2026
- GLAXOSMITHKLINE, S.A.
- Merck Sharp & Dohme de España, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
19 June 2026
Contracting authority
Consejería de Sanidad de la Comunidad de Madrid
Procuring entityMadrid, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.